Mackenzie Financial Corp Ascendis Pharma A/S Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$121.07 - $153.67 $25,182 - $31,963	-208 Reduced 3.76%	5,319 $725,000
Q1 2024 May 10, 2024	BUY	$123.45 - $159.4 $132,338 - $170,876	1,072 Added 24.06%	5,527 $835,000
Q4 2023 Jan 30, 2024	SELL	$86.1 - $127.36 $17,047 - $25,217	-198 Reduced 4.26%	4,455 $561,000
Q3 2023 Oct 25, 2023	SELL	$86.5 - $103.97 $30,534 - $36,701	-353 Reduced 7.05%	4,653 $435,000
Q2 2023 Aug 03, 2023	SELL	$69.96 - $97.84 $65,692 - $91,871	-939 Reduced 15.79%	5,006 $446,000
Q1 2023 Apr 24, 2023	SELL	$104.9 - $126.78 $48,988 - $59,206	-467 Reduced 7.28%	5,945 $637,000
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $72,874 - $96,734	733 Added 12.91%	6,412 $783,000
Q3 2022 Oct 07, 2022	BUY	$84.03 - $110.23 $116,297 - $152,558	1,384 Added 32.22%	5,679 $586,000
Q2 2022 Aug 10, 2022	BUY	$78.08 - $117.61 $108,765 - $163,830	1,393 Added 48.0%	4,295 $399,000
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $523,570 - $695,583	-5,124 Reduced 63.84%	2,902 $341,000
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $64,693 - $86,356	-509 Reduced 5.96%	8,026 $1.08 Million
Q3 2021 Nov 08, 2021	SELL	$112.67 - $176.92 $51,264 - $80,498	-455 Reduced 5.06%	8,535 $1.36 Million
Q2 2021 Aug 11, 2021	SELL	$121.62 - $145.29 $81,485 - $97,344	-670 Reduced 6.94%	8,990 $1.18 Million
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $76,201 - $105,731	610 Added 6.74%	9,660 $1.25 Million
Q4 2020 Feb 10, 2021	BUY	$151.2 - $182.76 $66,225 - $80,048	438 Added 5.09%	9,050 $1.51 Million
Q3 2020 Nov 13, 2020	BUY	$134.29 - $154.32 $105,149 - $120,832	783 Added 10.0%	8,612 $1.33 Million
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $24,834 - $34,946	-224 Reduced 2.78%	7,829 $1.16 Million
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $24,155 - $36,132	-249 Reduced 3.0%	8,053 $906,000
Q4 2019 Feb 13, 2020	SELL	$91.45 - $139.12 $47,554 - $72,342	-520 Reduced 5.89%	8,302 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$95.8 - $118.9 $120,037 - $148,981	1,253 Added 16.55%	8,822 $850,000
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $810,715 - $999,789	7,569 New	7,569 $872,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account